Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Regulatory & Legal View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹1206.80

prior close

₹1206.80

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%+0.2% vs market

Pharmaceuticals peers, median of 160sector-0.1%-0.1% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Smallcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.3

15m

+0.0

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-0.4+0.2-0.1-0.1

Next day

-3.0-1.9-1.1-0.9-2.1

-6.6-0.7-5.8-0.2-6.3

-4.1-0.7-3.5+0.3-4.5

-2.6+0.0-2.7+1.1-3.7

-3.0-0.1-3.0+0.2-3.2

-1.5+1.3-2.8+1.0-2.5

15d

-27.9-0.2-27.7-0.2-27.7

-29.8+3.0-32.8+1.7-31.5

-19.7+7.8-27.5+7.9-27.6

-25.9+9.1-35.0+8.1-34.1

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma has received a demand notice dated 12th May 2026 from the National Pharmaceutical Pricing Authority (NPPA). The notice directs the company to deposit ₹4,92,25,923 (approximately ₹4.92 crore), which includes the overcharge amount, penalty, and interest. The NPPA alleges that the company overcharged for 2 drugs during the period April 2023 to November 2023, in violation of the Drugs Price Control Order, 2013. The company has clarified that there is no material impact on its financial, operational, or other activities as a result of this demand.

Likely market impact

While the demand amount of around ₹4.92 crore is material in absolute terms, the company has stated there is no material operational or financial impact. The stock may see minor negative sentiment due to the regulatory notice, but the company's dismissal of material impact should limit downside pressure.